Maree Bilandzic

1.2k total citations
29 papers, 884 citations indexed

About

Maree Bilandzic is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Maree Bilandzic has authored 29 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Reproductive Medicine. Recurrent topics in Maree Bilandzic's work include Ovarian cancer diagnosis and treatment (9 papers), Cancer Cells and Metastasis (9 papers) and TGF-β signaling in diseases (8 papers). Maree Bilandzic is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Cancer Cells and Metastasis (9 papers) and TGF-β signaling in diseases (8 papers). Maree Bilandzic collaborates with scholars based in Australia. Maree Bilandzic's co-authors include Kaye L. Stenvers, Jock K. Findlay, Andrew N. Stephens, Nuzhat Ahmed, Rodney B. Luwor, Hong‐Jian Zhu, Jan Pyman, Michael Quinn, Erik W. Thompson and Ardian Latifi and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Maree Bilandzic

27 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maree Bilandzic Australia 17 391 351 196 157 154 29 884
Kenji Unno United States 16 519 1.3× 248 0.7× 180 0.9× 165 1.1× 145 0.9× 22 994
Gary K. Yiu United States 13 990 2.5× 379 1.1× 282 1.4× 245 1.6× 137 0.9× 15 1.5k
Laura M. Handel United States 11 444 1.1× 335 1.0× 208 1.1× 100 0.6× 59 0.4× 13 812
Karolina Sterzyńska Poland 18 428 1.1× 325 0.9× 90 0.5× 226 1.4× 101 0.7× 36 811
Muayad A. Zahalka Israel 12 598 1.5× 203 0.6× 56 0.3× 89 0.6× 148 1.0× 20 919
Marsela Braunstein Canada 11 638 1.6× 450 1.3× 485 2.5× 374 2.4× 320 2.1× 15 1.4k
Angelina I. Londoño-Joshi United States 10 658 1.7× 267 0.8× 70 0.4× 200 1.3× 150 1.0× 13 901
Gert Jan Meersma Netherlands 16 497 1.3× 286 0.8× 146 0.7× 190 1.2× 85 0.6× 27 859
Tyvette S. Hilliard United States 13 365 0.9× 379 1.1× 175 0.9× 112 0.7× 198 1.3× 25 871
Saiful Effendi Syafruddin Malaysia 16 593 1.5× 199 0.6× 54 0.3× 253 1.6× 146 0.9× 40 992

Countries citing papers authored by Maree Bilandzic

Since Specialization
Citations

This map shows the geographic impact of Maree Bilandzic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maree Bilandzic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maree Bilandzic more than expected).

Fields of papers citing papers by Maree Bilandzic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maree Bilandzic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maree Bilandzic. The network helps show where Maree Bilandzic may publish in the future.

Co-authorship network of co-authors of Maree Bilandzic

This figure shows the co-authorship network connecting the top 25 collaborators of Maree Bilandzic. A scholar is included among the top collaborators of Maree Bilandzic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maree Bilandzic. Maree Bilandzic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yao, et al.. (2024). Podocalyxin promotes the formation of compact and chemoresistant cancer spheroids in high grade serous carcinoma. Scientific Reports. 14(1). 7539–7539. 2 indexed citations
3.
Stephens, Andrew N., et al.. (2024). Challenges in Implementing Comprehensive Precision Medicine Screening for Ovarian Cancer. Current Oncology. 31(12). 8023–8038. 7 indexed citations
4.
Wilson, Amy L., et al.. (2024). Leader Cells: Invade and Evade—The Frontline of Cancer Progression. International Journal of Molecular Sciences. 25(19). 10554–10554. 4 indexed citations
5.
Jobling, Thomas W., et al.. (2024). Leader cells promote immunosuppression to drive ovarian cancer progression in vivo. Cell Reports. 43(11). 114979–114979. 1 indexed citations
6.
Stephens, Andrew N., Maree Bilandzic, Adam Rainczuk, et al.. (2023). A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer. Cancers. 15(21). 5267–5267. 5 indexed citations
7.
Green, Emma, et al.. (2021). Chemoresistance is mediated by ovarian cancer leader cells in vitro. Journal of Experimental & Clinical Cancer Research. 40(1). 276–276. 14 indexed citations
8.
Escalona, Ruth M., Maree Bilandzic, Patrick Western, et al.. (2020). TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. BMC Cancer. 20(1). 960–960. 33 indexed citations
9.
Bilandzic, Maree, Amy L. Wilson, Yiqian Chen, et al.. (2020). Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells. International Journal of Molecular Sciences. 21(21). 8110–8110. 16 indexed citations
10.
Evans, Jemma, et al.. (2019). A novel “embryo-endometrial” adhesion model can potentially predict “receptive” or “non-receptive” endometrium. Journal of Assisted Reproduction and Genetics. 37(1). 5–16. 24 indexed citations
11.
Sandow, Jarrod J., Adam Rainczuk, Giuseppe Infusini, et al.. (2018). Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine. PROTEOMICS - CLINICAL APPLICATIONS. 12(3). e1700135–e1700135. 41 indexed citations
12.
Greening, David W., Ruth M. Escalona, Maoshan Chen, et al.. (2017). Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling. Scientific Reports. 7(1). 46312–46312. 16 indexed citations
13.
Wang, Yao, Maree Bilandzic, Guck T. Ooi, Jock K. Findlay, & Kaye L. Stenvers. (2016). Endogenous inhibins regulate steroidogenesis in mouse TM3 Leydig cells by altering SMAD2 signalling. Molecular and Cellular Endocrinology. 436. 68–77. 7 indexed citations
14.
Bilandzic, Maree & Kaye L. Stenvers. (2014). Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time. Journal of Visualized Experiments. 17 indexed citations
15.
Bilandzic, Maree, Yao Wang, Nuzhat Ahmed, et al.. (2014). Betaglycan blocks metastatic behaviors in human granulosa cell tumors by suppressing NFκB-mediated induction of MMP2. Cancer Letters. 354(1). 107–114. 19 indexed citations
16.
Cuman, Carly, Ellen Menkhorst, Luk Rombauts, et al.. (2013). Preimplantation human blastocysts release factors that differentially alter human endometrial epithelial cell adhesion and gene expression relative to IVF success. Human Reproduction. 28(5). 1161–1171. 45 indexed citations
17.
Latifi, Ardian, Rodney B. Luwor, Maree Bilandzic, et al.. (2012). Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors. PLoS ONE. 7(10). e46858–e46858. 182 indexed citations
18.
Bilandzic, Maree & Kaye L. Stenvers. (2012). Reprint of: Betaglycan: A multifunctional accessory. Molecular and Cellular Endocrinology. 359(1-2). 13–22. 16 indexed citations
19.
Bilandzic, Maree & Kaye L. Stenvers. (2011). Betaglycan: A multifunctional accessory. Molecular and Cellular Endocrinology. 339(1-2). 180–189. 96 indexed citations
20.
Bilandzic, Maree, Simon Chu, Paul G. Farnworth, et al.. (2009). Loss of Betaglycan Contributes to the Malignant Properties of Human Granulosa Tumor Cells. Molecular Endocrinology. 23(4). 539–548. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenji Unno Breakdown of academic impact, for papers by Gary K. Yiu Breakdown of academic impact, for papers by Laura M. Handel Breakdown of academic impact, for papers by Karolina Sterzyńska Breakdown of academic impact, for papers by Muayad A. Zahalka Breakdown of academic impact, for papers by Marsela Braunstein Breakdown of academic impact, for papers by Angelina I. Londoño-Joshi Breakdown of academic impact, for papers by Gert Jan Meersma Breakdown of academic impact, for papers by Tyvette S. Hilliard Breakdown of academic impact, for papers by Saiful Effendi Syafruddin
Rankless by CCL
2026